INTRABIO
IntraBio is a biopharmaceutical company with a late-stage drug pipeline that includes novel treatments for genetic and neurodegenerative diseases. Their clinical programs leverage the expertise of their scientific founders from the University of Oxford and University of Munich, the preeminent experts and pioneers in discovering and developing small molecule drugs that modulate lysosomal function and intracellular calcium signaling. Their management team and business consultants have vast comme... rcial and regulatory experience in drug product development, including all stages from small molecule manufacturing, clinical studies, and regulatory approvals in the USA and Europe. With their successful track record of drug development and commercialization, IntraBio’s team translates research in the fields of lysosomal biology, autophagy, and neurology into orphan drugs and treatments that will significantly improve the lives of patients, their caregivers, and families.
INTRABIO
Social Links:
Industry:
Biotechnology Pharmaceutical
Founded:
2015-01-01
Address:
Oxford, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.intrabio.com
Total Employee:
11+
Status:
Active
Contact:
8770 386-7402
Total Funding:
10.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome Wordpress Plugins Nginx
Similar Organizations
Allero Therapeutics
Allero Therapeutics is a biopharmaceutical company.
Aurealis Pharma
Aurealis Pharma is a biopharmaceutical company.
Biocytogen
Biopharmaceutical company.
Biomanda
Biomanda is a bioinformatics service provider company.
Circadian Therapeutics
Circadian Therapeutics is a Pharmaceutical company.
Curacyte Discovery GmbH
Curacyte Discovery is an advanced biopharmaceutical company.
Kanova
Kanova is a biopharmaceutical firm.
Leukos Biotech
Leukos Biotech is a biopharmaceutical company
Origo Biopharma
Origo Biopharma is a biotech company.
Pharmarctica
Pharmarctica is a pharmaceutical company.
Samsung Bioepis
Samsung Bioepis is a biopharmaceutical company.
Virovet
ViroVet is a pioneering company.
Zentera Therapeutics
Zentera Therapeutics is a biopharmaceutical company.
Current Employees Featured
Founder
Official Site Inspections
http://www.intrabio.com Semrush global rank: 5.76 M Semrush visits lastest month: 1.45 K
- Host name: 114.8.214.35.bc.googleusercontent.com
- IP address: 35.214.8.114
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "IntraBio"
IntraBio - Crunchbase Company Profile & Funding
IntraBio is a biopharmaceutical company with a late-stage drug pipeline that includes novel treatments for genetic and neurodegenerative diseases. Their clinical programs leverage the expertise of their scientific founders from the …See details»
Our Team - IntraBio
Board of Directors Mallory Factor, ChairmanFull bio above Elizabeth Factor, Chief Admin OfficerFull bio above Christopher YegenInvestor and Philanthropist Dr. Ali KhanDean of Public …See details»
IntraBio - The Org
IntraBio is a biopharmaceutical company with a late-stage drug pipeline that includes novel treatments for genetic and neurodegenerative diseases.Their clinical programs leverage the …See details»
What We Do - IntraBio
IntraBio is a biopharmaceutical company focused on discovering, developing, and commercializing therapies for neurodegenerative diseases with high unmet medical needs Our …See details»
IntraBio, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore IntraBio, Inc. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, 3 news, and 5 literature, Disease Domain:Endocrinology and ...See details»
IntraBio Company Profile 2024: Valuation, Funding
IntraBio General Information Description. Developer of small-molecule therapies intended to offer treatment for rare and neurodegenerative diseases. The company's therapies include small molecule drugs that modulate the …See details»
Intrabio Inc. Company Profile | Tenafly, NJ - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Intrabio Inc. of Tenafly, NJ. Get the latest business insights from Dun & Bradstreet.See details»
IntraBio Company Profile - Office Locations, Competitors ... - Craft
IntraBio is a biopharmaceutical company that specializes in therapies for genetic and neurodegenerative diseases. It provides the development and commercialization of drug …See details»
IntraBio - VentureRadar
" IntraBio is a biopharmaceutical company with a late-stage drug pipeline that includes novel treatments for genetic and neurodegenerative diseases. Our clinical programs leverage the …See details»
IntraBio - Contacts, Employees, Board Members, Advisors & Alumni
IntraBio is a biopharmaceutical company. Unlock even more features with Crunchbase ProSee details»
IntraBio - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Mar 23, 2024: Venture Round - …See details»
US FDA approves IntraBio's drug for rare genetic disease
Sep 24, 2024 The U.S. Food and Drug Administration approved IntraBio's drug for a rare and fatal genetic disorder, the health regulator said on Tuesday, just days after the agency cleared …See details»
IntraBio Completes Recruitment for IB1001 NPC Pivotal Clinical Trial
Dec 8, 2022 IntraBio Inc announced today that it has completed recruitment for its Pivotal Trial, Effects of N-Acetyl-L-Leucine on Niemann-Pick disease type C (NPC): A Phase III, …See details»
Pipeline - IntraBio
IntraBio’s platform technology results from decades of research and over $350 million of investments from organizations worldwide. Our pipeline has broad applicability to be …See details»
IntraBio Announces U.S. FDA Accepts New Drug Application for …
Mar 26, 2024 IntraBio's IB1001 New Drug Application was accepted and granted priority review PDUFA date set for September 24th, 2024 Application based on positive results of the IB1001 …See details»
IntraBio Update - Yahoo Finance
Apr 12, 2023 IntraBio is developing other assets-its IB2000, IB3000, IB4000, and IB5000 series. Series C Funding Round Completed and Closed April 5 th, 2023. IntraBio, a late-stage …See details»
Submissions – IntraBio
Investigator Sponsored Studies (ISS) Program / Submission Process IntraBio is committed to advancing medical research and improving patient outcomes through collaboration with …See details»
IntraBio hits the ground running with new rare disease launch
Sep 30, 2024 With its first approval in hand, privately held IntraBio is embarking upon the difficult task of marketing a drug for an ultra-rare disease. Still, with months of prep work and outreach …See details»
Lead Program - IntraBio
IB1001IB1001 is an orally administered, modified amino acid (N-Acetyl-L-Leucine). Its safety and tolerability profile has been studied extensively in clinical trials. Given the extremely high, …See details»